SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents

SPIRIVA RESPIMAT is the first new class of inhaled medicine approved in over 10 years for the treatment of asthmaSPIRIVA RESPIMAT works differently than other medicines to help people with asthma breathe better
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news